Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Akkermansia muciniphila (pasteurized postbiotic)

Pasteurized Akkermansia muciniphila · also known as AKK bacteria, Akkermansia muciniphila, Pasteurized AKK

In mouse studies, pasteurized Akkermansia (a postbiotic) can improve markers of the mucus barrier and tight junctions. Direct human evidence is still limited, and an improvement in glucose and lipid metabolism or in the intestinal barrier cannot yet be confirmed.

Typical dose: About 10^9 to 10^10 inactivated-cell equivalents per day, taken with a meal
Absorption and forms: Live bacteria are hard to keep stable at room temperature and demanding to culture, so pasteurized preparations are common. The effect of inactivation depends on the strain, the manufacturing process and the endpoint measured. It cannot be assumed that inactivation necessarily makes proteins more accessible, and potency does not double as a result.

Clinical uses and human evidence

Blood sugar and insulin resistance

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Suenaert 2026 · Gut Microbes · RCT · n=142 — Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels
  2. Depommier 2019 · Nat Med · RCT · n=40 — Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

Body weight and body fat

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Mount 2026 · Nat Med · RCT · n=90 — Pasteurized Akkermansia muciniphila Muc(T) for weight loss maintenance in people with overweight and obesity: a controlled randomized trial
  2. Depommier 2019 · Nat Med · RCT · n=40 — Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

Muscle strength and mass

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Kang 2024 · Nutrients · RCT · n=100 — Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Polycystic ovary syndrome

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Zeng 2026 · Clin Nutr · RCT · n=100 — Adjunctive Akkermansia muciniphila postbiotic supplementation modulates metabolic and endocrine profiles in obesity-associated polyendocrine metabolic ovarian syndrome: A randomized controlled trial

Mechanisms of action

Secretion of intestinal mucin (MUC2) and the protective mucus gel layer

★★★☆☆Mechanism evidence: grade CSecondary target

In a mouse antibiotic-associated diarrhea model, pasteurized bacteria improved barrier markers such as Muc2. Cell experiments show that Amuc_1100 can activate TLR2, but the full chain from TLR2 to MUC2 secretion and then to a thicker mucus layer in humans has not been confirmed.

References (2)
  1. Liu et al. 2024 · Mouse antibiotic-associated diarrhea model: pasteurized bacteria or Amuc_1100 improved barrier markers such as Muc2
  2. Plovier et al. 2017 · Cell and mouse study: Amuc_1100 can activate TLR2 in cells, and pasteurized bacteria had metabolic effects in mice

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

In animal studies, inactivated bacteria can upregulate tight-junction proteins such as ZO-1 and occludin and limit their downregulation. In humans, changes in blood endotoxin or metabolic markers cannot prove that tight-junction proteins are upregulated, nor do they show that bacterial products entering the blood are fully blocked.

References (2)
  1. Liu et al. 2024 · Mouse antibiotic-associated diarrhea model: pasteurized bacteria lessened the downregulation of ZO-1, occludin and claudin-4
  2. Yang et al. 2026 · Obese mouse study: a specific inactivated strain upregulated ZO-1 and occludin

AMPK sensing of cellular energy deficit and metabolic reprogramming

★★★☆☆Mechanism evidence: grade CSecondary target

AMPK-related changes come from mouse and cell experiments. For example, GLP-1 and AMPK-related markers changed in a study of a specific inactivated strain. But no reliable human study has measured tissue AMPK activation after oral intake of inactivated bacteria, and a causal link between GLP-1 and liver AMPK has not been established.

References (2)
  1. Ma et al. 2025 · Mouse and cell study: Akkermansia and inactivated bacteria affected jejunal lipid absorption, and the experiments involved AMPK signaling
  2. Yang et al. 2026 · Obese mouse study: GLP-1 and AMPK-related markers changed with a specific pasteurized strain

Pattern recognition receptor (PRR) immune surveillance and trained immunity

★★★☆☆Mechanism evidence: grade CPrimary target

Amuc_1100 can activate TLR2 in cells. In mouse studies, loss of TLR2 partly cancels the effect of purified Amuc_1100. But this evidence comes from a purified protein and cannot directly show that whole inactivated bacteria have the same immune effect in humans.

References (1)
  1. Song et al. 2023 · Mouse study: loss of TLR2 partly canceled the effect of purified Amuc_1100

Safety and drug interactions

Pasteurized products contain no live bacteria, so they carry no risk of uncontrolled colonization by live bacteria. That does not guarantee the product is absolutely risk-free for everyone. Safety data for long-term use and for special populations are still limited.
Open in the interactive app ›